Will Patent Waivers Make Covid Vaccines More Accessible?
A Latin America Advisor Q&A on Biden’s decision to support waiving patents for Covid-19 vaccines and its implications for Latin America.
Area Head of Latin America at Roche Pharma,
˙
Rolf Hoenger is the area head of Roche Pharma Latin America and an advisory board member at Movimiento Salud 2030. Hoenger has a long trajectory in the region, where he has held several positions, including general manager for Roche Peru, Colombia and Ecuador, commercial development director for Latin America, marketing and sales manager for Central America and the Caribbean, and, most recently, general manager of Roche Brazil.
He started his career at Roche Group in 1993 as market manager of Central Asia, where he founded the company’s operations in these countries. Hoenger holds a degree in economics from the University of St. Gallen, Switzerland.
Role at the Dialogue: Event Speaker
A Latin America Advisor Q&A on Biden’s decision to support waiving patents for Covid-19 vaccines and its implications for Latin America.
A Latin America Advisor Q&A featuring experts’ viewpoints on improving Latin America and the Caribbean’s health care.